MYGN vs XLP
Myriad Genetics Inc (MYGN) versus XLP (XLP) — a side-by-side from cached financials, not a winner call.
Myriad Genetics Inc (MYGN) is a diagnostics & research company listed on NASDAQ.
XLP (XLP) common stock.
Latest reported MYGN revenue for 2025-12-31 was $824.5M. Net income was -$365.9M. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. MYGN currently screens at market cap $413.7M.
XLP does not have a complete income-statement cache yet.
MYGN currently screens at market cap $413.7M. XLP currently screens at market cap $0.
Not investment advice. Open the MYGN and XLP stock pages for the full models.
Not investment advice.